David Shaw D.E. Shaw & Co
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$9.63B |
| 2 |
Amazon
AMZN
|
+$1.56B |
| 3 |
NVIDIA
NVDA
|
+$1.1B |
| 4 |
Meta Platforms (Facebook)
META
|
+$924M |
| 5 |
SPCX
SpaceX
SPCX
|
+$907M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Micron Technology
MU
|
+$2.17B |
| 2 |
Broadcom
AVGO
|
+$1.53B |
| 3 |
Microsoft
MSFT
|
+$1.05B |
| 4 |
TSMC
TSM
|
+$928M |
| 5 |
Texas Instruments
TXN
|
+$904M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.78% |
| 2 | Financials | 8.35% |
| 3 | Healthcare | 7.91% |
| 4 | Consumer Discretionary | 7.83% |
| 5 | Industrials | 7.54% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
926
Astronics
ATRO
$3.21B
| $33M | 0.02% |
406,571
-323,568
| -44% | -$22.1M |
|
927
CALL
PepsiCo
PEP
$197B
| $33M | 0.02% |
243,900
-74,200
| -23% | -$11.1M |
|
928
iShares US Medical Devices ETF
IHI
$3.45B
| $33M | 0.02% |
667,627
+338,438
| +103% | +$17.2M |
|
929
PUT
Live Nation Entertainment
LYV
$43B
| $33M | 0.02% |
180,100
+900
| +0.5% | +$148K |
|
930
PUT
MP Materials
MP
$10.2B
| $32.9M | 0.02% |
587,900
-219,100
| -27% | -$13.3M |
|
931
Takeda Pharmaceutical
TAK
$58.2B
| $32.9M | 0.02% |
2,049,467
-553,076
| -21% | -$9.15M |
|
932
PUT
Take-Two Interactive
TTWO
$43.7B
| $32.8M | 0.02% |
131,400
+47,100
| +56% | +$10.4M |
|
933
PUT
Atlassian
TEAM
$43.4B
| $32.7M | 0.02% |
420,800
-303,700
| -42% | -$24.8M |
|
|
HAPN
934
Happen Inc
HAPN
$2.11B
| $32.7M | 0.02% |
1,576,086
+806,416
| +105% | +$13.7M |
|
935
Apogee Therapeutics
APGE
$10.2B
| $32.7M | 0.02% |
246,086
+187,251
| +318% | +$16.9M |
|
936
CALL
PayPal
PYPL
$52.8B
| $32.6M | 0.02% |
755,500
-40,000
| -5% | -$1.82M |
|
937
On Holding
ONON
$9.86B
| $32.6M | 0.02% |
920,124
+869,655
| +1,723% | +$31.8M |
|
938
Enphase Energy
ENPH
$4.91B
| $32.6M | 0.02% |
661,058
-1,667,698
| -72% | -$76M |
|
939
Liberty Global Class A
LBTYA
$3.66B
| $32.5M | 0.02% |
2,854,713
+1,562,596
| +121% | +$18.7M |
|
940
CareDx
CDNA
$2.46B
| $32.4M | 0.02% |
1,137,660
+262,752
| +30% | +$5.72M |
|
941
CALL
Markel Group
MKL
$22.5B
| $32.4M | 0.02% |
16,600
+10,000
| +152% | +$18.7M |
|
942
Service Corp International
SCI
$11.5B
| $32.4M | 0.02% |
426,067
+387
| +0.1% | +$30.3K |
|
943
Verisk Analytics
VRSK
$24.7B
| $32.3M | 0.02% |
179,819
-1,020,600
| -85% | -$180M |
|
944
PUT
Telus
TU
$15.5B
| $32.3M | 0.02% |
3,052,500
| – | – |
|
945
Bristol-Myers Squibb
BMY
$137B
| $32.2M | 0.02% |
559,407
+249,569
| +81% | +$14.3M |
|
946
Bright Horizons
BFAM
$3.6B
| $32.2M | 0.02% |
454,593
-55,571
| -11% | -$4.02M |
|
947
Enerpac Tool Group
EPAC
$1.9B
| $32.1M | 0.02% |
896,260
+181,148
| +25% | +$6.35M |
|
948
STMicroelectronics
STM
$44B
| $32.1M | 0.02% |
428,683
+378,431
| +753% | +$22.8M |
|
949
U-Haul Holding Co
UHAL
$13.8B
| $32.1M | 0.02% |
489,815
+197,537
| +68% | +$10.8M |
|
950
NeoGenomics
NEO
$2.11B
| $32M | 0.02% |
2,194,758
-1,969,425
| -47% | -$19M |
|
Similar funds
David Shaw's Q2 2026 Portfolio in Review
As of Q2 2026, David Shaw held 5,360 positions worth $210B, up 26% from $166B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
David Shaw deployed $7.01B of net new capital in Q2 2026, opening 872 new positions and adding to 1,718 existing holdings. Its largest new stake was SpaceX: 5,340,000 shares worth $912M.
By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 19% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Micron Technology, an estimated $2.17B trimmed.
- David Shaw's largest Q2 2026 buy was SpaceX: 5,340,000 shares worth $912M.
- David Shaw added most to State Street SPDR S&P 500 ETF Trust in Q2 2026, an estimated $9.63B increase.
- David Shaw's biggest Q2 2026 reduction was Micron Technology, cutting an estimated $2.17B.
- David Shaw fully exited Automatic Data Processing in Q2 2026, selling an estimated $241M.
- David Shaw's ten largest holdings make up 15% of its $210B portfolio in Q2 2026.
- David Shaw opened 872 new positions and closed 527 in Q2 2026.
- David Shaw's portfolio value rose 26% quarter-over-quarter to $210B.
Based on D.E. Shaw & Co's 13F filing for Q2 2026, filed 14 Aug 2026.